Connexion
Connexion
Ou se connecter avec
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Inscription
Ou se connecter avec
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Accueil Zonebourse
  2. Actions
  3. France
  4. Euronext Paris
  5. Sanofi
  6. Actualités
  7. Autres langues
    SAN   FR0000120578

SANOFI

(SAN)
  Rapport
Temps réel Euronext Paris  -  17:36:26 22/03/2023
90.86 EUR   +0.75%
21/03La réunion de la Fed et les banques sont au centre de l'attention alors que les fonds négociés en bourse et les contrats à terme sur actions augmentent mardi en avant-première.
MT
21/03USA-Les valeurs à suivre à Wall Street (actualisé)
RE
21/03Sanofi et Regeneron Pharmaceuticals annoncent que le Dupixent a obtenu l'approbation européenne pour le traitement de la dermatite atopique sévère chez l'enfant
MT
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur SANOFI
21/03Blue shield of california - low-cost insulin one step closer with california-civica par..
21/03Fed Policy Meeting, Banks in Focus as Exchange-Traded Funds, Equity Futures Rise Premar..
21/03Sanofi, Regeneron Pharmaceuticals Say Dupixent Obtains European Approval to Treat Sever..
21/03Bolsa de Madrid: Cueste lo que cueste...
21/03Sanofi, Regeneron's Dupixent Wins EU's First-in-Class Nod for Severe Atopic Dermatitis ..
21/03Press Release : Dupixent® (dupilumab) approved by European Commission as first and only ta..
21/03Press Release : Dupixent® (dupilumab) approved by European Commission as first and only ta..
21/03European Commission Approves Dupixent of Regeneron Pharmaceuticals, Inc. and Sanofi
20/03Vaccine makers prep bird flu shots for humans
20/03Bolsa de Madrid: Otro banco que muerde el polvo
20/03Vaccine makers prep bird flu shot for humans 'just in case'; rich nations lock in suppl..
18/03Press Release : Dupixent® (dupilumab) late-breaking data at AAD show significant improveme..
18/03Press Release : Dupixent® (dupilumab) late-breaking data at AAD show significant improveme..
17/03Healthcare Shares Decline With Focus on Drug Prices - Healthcare Roundup
17/03Borse Europa in rialzo su minori turbolenze bancarie, bene energia
17/03Bolsa de Madrid: ¿Fin de la Berezina?
17/03MORNING BRIEFING - Deutschland/Europa -2-
17/03MORNING BRIEFING - USA/Asien -2-
17/03Marketmind: Support for troubled banks calms markets
17/03France's Sanofi Joins Rivals in Slashing US Insulin Prices
17/03Sanofi cuts insulin cost to $35, third major drug company to do so
16/03Sanofi to cut US price of its most-prescribed insulin by 78%
16/03Diabetes-Medikamentenriese Sanofi senkt Insulinpreise drastisch
16/03Sanofi Cuts Lantus US List Price by 78%, Caps Insured Out-of-Pocket Cost to $35
16/03Sanofi to cut price of its most-prescribed insulin by 78% in US
16/03Sanofi Cuts US Price of Lantus Insulin by 78%
16/03Sanofi Cuts US Price of Lantus Insulin by 78%
16/03Press Release : Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78..
16/03Press Release : Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78..
14/03Sanofi Announces Acceptance of Dupixent Application for Treatment of Chronic Spontaneou..
14/03Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifyi..
14/03Novo Nordisk senkt Insulinpreise ab 2024 um bis zu 75 Prozent
14/03Novo Nordisk planea reducir hasta un 75% el precio de la insulina en EEUU
13/03Healthcare Shares Climb Amid Deal News -- Healthcare Roundup
13/03Aktien New York Schluss: Stabilisierung - Übernahmen stützen Nas..
13/03MÄRKTE USA/Wall Street uneinheitlich - Bankenwerte stürzen ab
13/03Bankendrama zet Wall Street onder druk
13/03Sector Update: Health Care Stocks Close with Solid Monday Gains
13/03Sector Update: Health Care Maintaining Monday Rebound
13/03Aktien New York: Stabilisierung trotz Bankenkrise - Übernahmen beflügen ..
13/03Top Midday Gainers
13/03Sector Update: Health Care
13/03Handel Wall Street volatiel
13/03LATE BRIEFING - Unternehmen und Märkte
13/03MÄRKTE EUROPA/Ausverkauf nach SVB-Schieflage - Banken brechen ein
13/03Dpa-AFX-Überblick: UNTERNEHMEN vom 13.03.2023 - 15.15 Uhr
13/03MÄRKTE EUROPA/DAX kämpft mit 15.000er-Marke - Lufthansa leiden unter Streiks
13/03Sector Update: Health Care Stocks Advance in Early Monday Morning Trade
13/03Sector Update: Health Care
13/03Traders Assess US Moves to Contain Bank Fallout, Prompting Lower Premarket Session for ..
13/03Futures Wall Street verdeeld
13/03ANALYSE/Regeneron hält Big Pharma mit deren Waffen in Schach
13/03Fed's US Bank Rescue Lifts Exchange-Traded Funds, Equity Futures Pre-Bell Monday
13/03MIDDAY BRIEFING - Unternehmen und Märkte -2-
13/03Top Premarket Gainers
13/03French Bourse Kicks Off Week Deep in Red after Silicon Valley Bank Collapse
13/03Sanofi to Acquire Provention Bio in $2.9 Billion Deal
13/03European Midday Briefing: Investors Weigh SVB Contagion Risk
13/03North American Morning Briefing: Investors Digest Emerge..
13/03Sanofi to Boost General Medicines Portfolio Via $3 Billion Takeover of US-based Provent..
13/03La francesa Sanofi compra la estadounidense Provention Bio por 2.900 millones de dólare..
13/03Sanofi stärkt Diabetes-Geschäft mit Milliardenzukauf
13/03Bolsa de Madrid: El Equipo A
13/03Sanofi will Provention Bio kaufen
13/03Sanofi kauft Provention Bio für rund 2,9 Mrd USD
13/03Live Stock Market Blog - March 13, 2023 - Business AM
13/03MORNING BRIEFING - Deutschland/Europa -2-
13/03Sanofi to Acquire Provention Bio for Around $2.9 Billion
13/03France's Sanofi to acquire US-based Provention Bio for $2.9 billion
13/03Sanofi to Buy Autoimmune Disease-focused Provention Bio for $2.9 Billion
13/03Sanofi neemt Provention Bio over in miljardendeal
13/03Galderma posts 2022 revenue growth ahead of planned IPO
13/03Press Release : Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first di..
13/03Sanofi (ENXTPA:SAN) entered into an agreement to acquire 97.023% stake in..
09/03US Lawmakers Introduce Bill Capping Insulin Price at $20 Per Vial
09/03Sanofi : Rapport Financiére
08/03Bolsa de Madrid: Don't fight the Fed, o de manera discreta
07/03Sanofi, Regeneron Say US FDA Accepted Supplemental Biologics License Application for Du..
07/03European Midday Briefing: Powell Testimony in Focus
07/03Bolsa de Madrid: Ha vuelto, pero ¿está contento?
07/03Sanofi, Regeneron Seek US FDA Nod for Dupixent's Use in Treating Hives
07/03Press Release : Dupixent® (dupilumab) application for treatment of chronic spontaneous urt..
07/03Regeneron Pharmaceuticals, Inc. and Sanofi Announce U.S. Food and Drug Administration A..
07/03Regeneron Pharmaceuticals, Inc. and Sanofi Announce U.S. Food and Drug Administration A..
07/03Sanofi Announces U.S. Food and Drug Administration Has Accepted, for Review, the Supple..
07/03Press Release : Dupixent® (dupilumab) application for treatment of chronic spontaneous urt..
06/03Sanofi inaugura su nueva sede central en España con 800 trabajadores
06/03Merck's drug boosts exercise capacity in pulmonary hypertension patients
06/03Merck's drug boosts exercise capacity in pulmonary hypertension patients
06/03Stada profitiert von Krankheitswelle und starkem Russland-Geschäft
02/03Correction: Sanofi, Sobi's Rare Bleeding Disorder Drug Shown Safe for Kids in..
02/03Successful Transaction : Adragos Pharma has officially taken over the Sanofi production si..
02/03Sanofi, Sobi's Rare Bleeding Disorder Drug Shown Safe for Kids in Late-stage Study
02/03Positive topline results from pivotal XTEND-Kids phase 3 study of efanesoctocog alfa in..
02/03Press Release : Completed XTEND-Kids Phase 3 study strengthens potential of ALTUVIIIOTM to..
02/03Sobi and Sanofi Announces Positive Topline Results from Pivotal XTEND- Kids Phase 3 Stu..
02/03Press Release : Completed XTEND-Kids Phase 3 study strengthens potential of ALTUVIIIOTM to..
02/03Merck KGaA expects 2023 profit to slip as COVID demand wanes
01/03Lilly reducirá un 70% el precio de la insulina en EEUU a partir del cuarto trimestre
01/03Eli Lilly to Cut Some Insulin Prices by 70%
Prochain événement sur SANOFI
Zonebourse : Créé par des Investisseurs pour des Investisseurs !
Inscription 100% Gratuite
fermer